- Home
- HBAN vs IQV Comparison
HBAN vs IQV Comparison
Compare HBAN & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBAN | IQV |
|---|---|---|
| Founded | 1866 | 1982 |
| Country | United States | United States |
| Employees | 24641 | 93000 |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.3B | 35.1B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | HBAN | IQV |
|---|---|---|
| Price | $17.32 | $209.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 16 |
| Target Price | $19.73 | ★ $227.13 |
| AVG Volume (30 Days) | ★ 22.0M | 1.2M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.80% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 1.61 |
| Revenue | N/A | ★ $9,739,000,000.00 |
| Revenue This Year | $50.83 | $6.77 |
| Revenue Next Year | $9.27 | $5.89 |
| P/E Ratio | ★ $12.87 | $128.77 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $14.89 | $154.50 |
| 52 Week High | $19.44 | $247.05 |
Technical Indicators
Market Signals| Indicator | HBAN | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 44.44 | 62.78 |
| Support Level | $17.14 | $206.72 |
| Resistance Level | $17.55 | $212.36 |
| Average True Range (ATR) | 0.37 | 5.79 |
| MACD | -0.11 | -0.87 |
| Stochastic Oscillator | 16.12 | 62.72 |
Price Performance
Historical ComparisonAbout HBAN Huntington Bancshares Incorporated
Huntington is a regional US bank with over $285 billion in assets. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About IQV IQVIA Holdings Inc.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.